Literature DB >> 7786988

Robust variance estimation for the case-cohort design.

W E Barlow1.   

Abstract

Large cohort studies of rare outcomes require extensive data collection, often for many relatively uninformative subjects. Sampling schemes have been proposed that oversample certain groups. For example, the case-cohort design of Prentice (1986, Biometrika 73, 1-11) provides an efficient method of analysis of failure time data. However, the variance estimate must explicitly correct for correlated score contributions. A simple robust variance estimator is proposed that allows for more complicated sampling mechanisms. The variance estimate uses a jackknife estimate of the variance of the individual influence function and is shown to be equivalent to a robust variance estimator proposed by Lin and Wei (1989, Journal of the American Statistical Association 84, 1074-1078) for the standard Cox model. Simulation results indicate excellent agreement with corrected asymptotic estimates and appropriate test size. The technique is illustrated with data evaluating the efficacy of mammography screening in reducing breast cancer mortality.

Entities:  

Mesh:

Year:  1994        PMID: 7786988

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  176 in total

1.  Computing the Cox model for case cohort designs.

Authors:  T M Therneau; H Li
Journal:  Lifetime Data Anal       Date:  1999-06       Impact factor: 1.588

2.  Exposure stratified case-cohort designs.

Authors:  O Borgan; B Langholz; S O Samuelsen; L Goldstein; J Pogoda
Journal:  Lifetime Data Anal       Date:  2000-03       Impact factor: 1.588

3.  Influence function based variance estimation and missing data issues in case-cohort studies.

Authors:  S D Mark; H Katki
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

Review 4.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

5.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.

Authors:  Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

6.  Comparison of estimators in nested case-control studies with multiple outcomes.

Authors:  Nathalie C Støer; Sven Ove Samuelsen
Journal:  Lifetime Data Anal       Date:  2012-03-02       Impact factor: 1.588

7.  Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.

Authors:  Stephen R Cole; Michael G Hudgens; Phyllis C Tien; Kathryn Anastos; Lawrence Kingsley; Joan S Chmiel; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2012-02-01       Impact factor: 4.897

8.  Arsenic Exposure in Relation to Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Cari L Tsinovoi; Pengcheng Xun; Leslie A McClure; Vivian M O Carioni; John D Brockman; Jianwen Cai; Eliseo Guallar; Mary Cushman; Frederick W Unverzagt; Virginia J Howard; Ka He
Journal:  Stroke       Date:  2017-12-06       Impact factor: 7.914

9.  Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Authors:  C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand
Journal:  Diabetologia       Date:  2007-08-22       Impact factor: 10.122

10.  Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China.

Authors:  Wenjin Li; Roberta M Ray; David B Thomas; Michael Yost; Scott Davis; Norman Breslow; Dao Li Gao; E Dawn Fitzgibbons; Janice E Camp; Eva Wong; Karen J Wernli; Harvey Checkoway
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.